Indication
Percutaneous Coronary Revascularization
2 clinical trials
1 product
1 drug
Product
FDY-5301Clinical trial
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Intravenous FDY 5301 in Patients With an Anterior ST-Elevation Myocardial InfarctionStatus: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
The Effects of Dietary Supplementation Allicor on the Effectiveness of Treatment of Patients After Coronary Arteria RevascularizationStatus: Recruiting, Estimated PCD: 2024-03-31
Drug
Varlilumab